These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12065572)

  • 41. [Prognostic factors for 72 patients with osteosarcoma of the extremity treated with neoadjuvant chemotherapy].
    Liu J; Guo W; Yang RL; Tang XD; Yang Y
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1166-70. PubMed ID: 19094683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction chemotherapy in non-metastatic high grade osteo sarcomas--results of pilot study at Cancer Institute (WIA), Madras.
    Rajkumar T; Maitreyan V; Sagar TG; Raj E; Chandrasekhar A; Mayilvahanan N; Vasanthan A; Sukumaran MS; Shanta V
    Indian J Cancer; 1992 Sep; 29(3):139-42. PubMed ID: 1292996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The management of osteosarcoma in adults.
    Souhami RL
    Clin Oncol (R Coll Radiol); 1990 Mar; 2(2):102-7. PubMed ID: 2261392
    [No Abstract]   [Full Text] [Related]  

  • 44. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol.
    Bacci G; Ferrari S; Longhi A; Forni C; Bertoni F; Fabbri N; Zavatta M; Versari M
    J Chemother; 2001 Feb; 13(1):93-9. PubMed ID: 11233808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: preliminary results in 131 cases treated preoperatively with methotrexate and cisdiamminoplatinum.
    Bacci G; Avella M; Capanna R; Boriani S; Dallari D; Galletti S; Giunti A; Madon E; Mancini A; Mercuri M
    Ital J Orthop Traumatol; 1988 Mar; 14(1):23-39. PubMed ID: 3235324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
    Tabone MD; Kalifa C; Rodary C; Raquin M; Valteau-Couanet D; Lemerle J
    J Clin Oncol; 1994 Dec; 12(12):2614-20. PubMed ID: 7989936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Intra-arterial combination chemotherapy using both regimen selected by chemosensitivity test and caffeine to increase effect for osteosarcoma in extremity].
    Yoh S; Isayama T; Yoshitake K; Fujihara A; Kanamiya T; Ogata K; Inoue K; Maehara Y; Baba H
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2315-9. PubMed ID: 7944468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
    Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
    Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
    Bacci G; Briccoli A; Mercuri M; Ferrari S; Bertoni F; Gasbarrini A; Fabbri N; Cesari M; Forni C; Campanacci M
    J Chemother; 1998 Feb; 10(1):69-76. PubMed ID: 9531078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteogenic progenitor cell potency after high-dose chemotherapy (COSS-96).
    Jäger M; Schultheis A; Westhoff B; Krauspe R
    Anticancer Res; 2005; 25(2A):947-54. PubMed ID: 15868932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
    Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
    Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
    Hawkins DS; Arndt CA
    Cancer; 2003 Dec; 98(11):2447-56. PubMed ID: 14635080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
    Zalupski MM; Rankin C; Ryan JR; Lucas DR; Muler J; Lanier KS; Budd GT; Biermann JS; Meyers FJ; Antman K
    Cancer; 2004 Feb; 100(4):818-25. PubMed ID: 14770440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary results.
    Bacci G; Picci P; Ferrari S; Sangiorgi L; Mercuri M; Bertoni F; Brach del Prever A; Tienghi A; Mancini A; Comandone A
    Chir Organi Mov; 1995; 80(1):1-10. PubMed ID: 7641534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aneurysmal bone cyst inadvertently treated with chemotherapy-A series of three cases.
    Deventer N; Deventer N; Gosheger G; Budny T; de Vaal M; Riegel A; Heitkoetter B; Kessler T; Poeppelmann M; Rossig C; Juergens H; Luebben T
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28638. PubMed ID: 32761959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methotrexate serum concentration and histological response to multiagent primary chemotherapy for osteosarcoma of the limbs.
    Bacci G; Ferrari S; Picci P; Zolezzi C; Gherlinzoni F; Iantorno D; Cazzola A
    J Chemother; 1996 Dec; 8(6):472-8. PubMed ID: 8981189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Neoadjuvant treatment of osteosarcoma and malignant fibrous histiocytoma of the bones of the extremities: preliminary results in 76 cases treated preoperatively with a methotrexate and cisplatin combination].
    Bacci G; Mercuri M; Pignatti G; Picci P; Guerra A; Albisinni U; Galletti S; Manfrini M; Orlandi M; Dallari D
    Chir Organi Mov; 1985; 70(4):303-14. PubMed ID: 3009102
    [No Abstract]   [Full Text] [Related]  

  • 58. Osteosarcoma treatment: state of the art.
    Ta HT; Dass CR; Choong PF; Dunstan DE
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):247-63. PubMed ID: 19214708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute.
    Bacci G; Ferrari S; Forni C; Mercuri M; Picci P; Bertoni F; Capanna R; Manfrini M; Donati D; Brach Del Prever A; Baldini N
    Chir Organi Mov; 1996; 81(4):369-82. PubMed ID: 9147928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.
    Bacci G; Longhi A; Fagioli F; Briccoli A; Versari M; Picci P
    Eur J Cancer; 2005 Dec; 41(18):2836-45. PubMed ID: 16298125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.